Interferon α in cancer immunoediting: From elimination to escape

被引：38
作者：
Vidal, Paolo [1 ]
机构：
[1] Univ Philippines, Dept Med Microbiol, Coll Publ Hlth, Manila, Philippines
来源：
SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 2020年 / 91卷 / 05期
关键词：
interferon alpha; pro-tumorigenic; STAT1; IFN-ALPHA; TUMOR-SUPPRESSOR; I INTERFERONS; SIGNAL TRANSDUCER; DENDRITIC CELLS; DNA-DAMAGE; T-CELLS; CONFERS RESISTANCE; TRAIL EXPRESSION; LUNG-CANCER;
D O I：
10.1111/sji.12863
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Interferon alpha (IFN alpha) is a cytokine that mediates diverse immune responses to tumours. It is the oldest immune-based oncologic drug and has been widely used to treat various malignancies in humans. Yet, the use of IFN alpha in cancer therapy has only resulted in limited success and even led to worse clinical outcomes under certain instances. The emergence of the cancer immunoediting concept-which implicates the host immune system in promoting tumour growth-recapitulates the need to evaluate the immune functions of IFN alpha. This review proposes that IFN alpha has dual opposing roles in cancer development based on the mutational status of its signalling components, which determines the expression of anti- or pro-tumorigenic IFN-stimulated genes (ISGs). This duality may translate into new applications of IFN alpha in cancer immunotherapy.
引用
收藏
页数：8
相关论文
共 94 条
  • [1] AFFABRIS E, 1987, HAEMATOLOGICA, V72, P76
  • [2] Free interferon-α/β receptors in the circulation of patients with adenocarcinoma
    Ambrus, JL
    Dembinski, W
    Ambrus, JL
    Sykes, DE
    Akhter, S
    Kulaylat, MN
    Islam, A
    Chadha, KG
    [J]. CANCER, 2003, 98 (12) : 2730 - 2733
  • [3] Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer
    Andersen, J. B.
    Aaboe, M.
    Borden, E. C.
    Goloubeva, O. G.
    Hassel, B. A.
    Orntoft, T. F.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1465 - 1471
  • [4] Growing tumors induce a local STING dependent Type I IFN response in dendritic cells
    Andzinsk, Lisa
    Spanier, Julia
    Kasnitz, Nadine
    Kroeger, Andrea
    Jin, Lei
    Brinkmann, Melanie M.
    Kalinke, Ulrich
    Weiss, Siegfried
    Jablonska, Jadwiga
    Lienenklaus, Stefan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (06) : 1350 - 1357
  • [5] BARAL E, 1977, CANCER-AM CANCER SOC, V40, P2905, DOI 10.1002/1097-0142(197712)40:6<2905::AID-CNCR2820400621>3.0.CO
  • [6] 2-Y
  • [7] Barnes BJ, 2003, CANCER RES, V63, P6424
  • [8] The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
    Bektas, Nuran
    Noetzel, Erik
    Veeck, Juergen
    Press, Michael F.
    Kristiansen, Glen
    Naami, Amjad
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Knuechel, Ruth
    Fasching, Peter A.
    Dahl, Edgar
    [J]. BREAST CANCER RESEARCH, 2008, 10 (04):
  • [9] Interferon-alpha in tumor immunity and immunotherapy
    Belardelli, F
    Ferrantini, M
    Proietti, E
    Kirkwood, JM
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 119 - 134
  • [10] Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
    Bidwell, Bradley N.
    Slaney, Clare Y.
    Withana, Nimali P.
    Forster, Sam
    Cao, Yuan
    Loi, Sherene
    Andrews, Daniel
    Mikeska, Thomas
    Mangan, Niamh E.
    Samarajiwa, Shamith A.
    de Weerd, Nicole A.
    Gould, Jodee
    Argani, Pedram
    Moeller, Andreas
    Smyth, Mark J.
    Anderson, Robin L.
    Hertzog, Paul J.
    Parker, Belinda S.
    [J]. NATURE MEDICINE, 2012, 18 (08) : 1224 - 1231
12345678910